Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcos de Lima

Showing results (71-80 of 321) with videos related to

Pageof 33
Sort By:
Radiology|November 9, 2021
Imaging-based Toxicity and Response Pattern Assessment Following CAR T-Cell TherapyDaniel A Smith, Elias Kikano, Sree Harasha Tirumani, et al.
Current Opinion in Oncology|June 30, 2009
Reduced-toxicity conditioning therapy with allogeneic stem cell transplantation for acute leukemiaBorje S Andersson, Marcos de Lima, Peter F Thall, et al.
Plos One|May 3, 2018
Correction: Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer modelsFolashade Otegbeye, Evelyn Ojo, Stephen Moreton, et al.
American Journal of Blood Research|March 21, 2012
Infectious complications in cord blood and T-cell depleted haploidentical stem cell transplantationVictor E Mulanovich, Ying Jiang, Marcos de Lima, et al.
Revista Brasileira De Hematologia E Hemoterapia|July 18, 2014
Transmission of lupus anticoagulant by allogeneic stem cell transplantationMira Romany Massoud, Basem M William, Katrina Harrill, et al.
Plos One|January 18, 2018
Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer modelsFolashade Otegbeye, Evelyn Ojo, Stephen Moreton, et al.
Virology Journal|October 16, 2020
Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agentsSumanth Khadke, Nayla Ahmed, Nausheen Ahmed, et al.
Hematology & Medical Oncology|November 25, 2016
Intra-osseous Co-transplantation of CD34-selected Umbilical Cord Blood and Mesenchymal Stromal CellsLeland Metheny, Saada Eid, Karen Lingas, et al.
Best Practice & Research. Clinical Haematology|March 15, 2011
Mesenchymal stem cells in ex vivo cord blood expansionSimon N Robinson, Paul J Simmons, Hong Yang, et al.
Oncology (Williston Park, N.Y.)|February 26, 2003
Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Biology and current indicationsRichard Champlin, Issa Khouri, Paolo Anderlini, et al.
Pageof 33

Showing results (71-80 of 321) with videos related to

Sort By:
Pageof 33
Radiology|November 9, 2021
Imaging-based Toxicity and Response Pattern Assessment Following CAR T-Cell TherapyDaniel A Smith, Elias Kikano, Sree Harasha Tirumani, et al.
Current Opinion in Oncology|June 30, 2009
Reduced-toxicity conditioning therapy with allogeneic stem cell transplantation for acute leukemiaBorje S Andersson, Marcos de Lima, Peter F Thall, et al.
Plos One|May 3, 2018
Correction: Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer modelsFolashade Otegbeye, Evelyn Ojo, Stephen Moreton, et al.
American Journal of Blood Research|March 21, 2012
Infectious complications in cord blood and T-cell depleted haploidentical stem cell transplantationVictor E Mulanovich, Ying Jiang, Marcos de Lima, et al.
Revista Brasileira De Hematologia E Hemoterapia|July 18, 2014
Transmission of lupus anticoagulant by allogeneic stem cell transplantationMira Romany Massoud, Basem M William, Katrina Harrill, et al.
Plos One|January 18, 2018
Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer modelsFolashade Otegbeye, Evelyn Ojo, Stephen Moreton, et al.
Virology Journal|October 16, 2020
Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agentsSumanth Khadke, Nayla Ahmed, Nausheen Ahmed, et al.
Hematology & Medical Oncology|November 25, 2016
Intra-osseous Co-transplantation of CD34-selected Umbilical Cord Blood and Mesenchymal Stromal CellsLeland Metheny, Saada Eid, Karen Lingas, et al.
Best Practice & Research. Clinical Haematology|March 15, 2011
Mesenchymal stem cells in ex vivo cord blood expansionSimon N Robinson, Paul J Simmons, Hong Yang, et al.
Oncology (Williston Park, N.Y.)|February 26, 2003
Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Biology and current indicationsRichard Champlin, Issa Khouri, Paolo Anderlini, et al.
Pageof 33